$1.880
+0.041 (+2.18%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PCSA por análisis de gráficos similares
Alphio's PCSA stock price prediction model matches the current Processa Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.92 (+2.37%). The 1-week path is $1.91 (+1.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Processa Pharmaceuticals Inc?
Processa Pharmaceuticals Inc (PCSA) is currently trading at $1.88, significantly down from its 52-week high of $8.88, indicating a 78.21% decline over the past year. The RSI is at 61.154, suggesting it is nearing overbought territory, which could limit short-term upside. Although there has been insider buying totaling about $40,000, the stock fell 38% after announcing a $200 million acquisition, reflecting market skepticism. The main risk is the company's negative earnings trend, with an EPS of -1.75 reported recently, indicating ongoing financial struggles.
PCSA cerró en $1.88 el Friday, tras subir +2.18%
Processa Pharmaceuticals Inc (PCSA) last closed at $1.8801, gaining +2.18%. These facts feed the 1-day and 1-week PCSA price prediction above.
Factores de la previsión
Los factores de la previsión de Processa Pharmaceuticals Inc (PCSA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PCSA, ordenadas por similitud.
Análisis de estacionalidad de PCSA
Historically the probability of a positive November return for PCSA is 0.00%. January offers the highest probability of a positive month at 37.70%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PCSA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.16 | $0.20 | $0.23 | -89.20% |
| Dec 2026 | $0.18 | $0.21 | $0.24 | -88.75% |
En 2026, se proyecta que Processa Pharmaceuticals Inc (PCSA) oscile entre $0.16 y $0.24.
Previsión mensual de Processa Pharmaceuticals Inc para 2026
En Nov de 2026, se proyecta que Processa Pharmaceuticals Inc promedie $0.20, con un mínimo de $0.16 y un máximo de $0.23.
En Dec de 2026, se proyecta que Processa Pharmaceuticals Inc promedie $0.21, con un mínimo de $0.18 y un máximo de $0.24.
Artículos relacionados
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.